- DOJ’s Withdrawal of Policy Statements Relating to Antitrust Enforcement in Healthcare Markets
(April 6, 2023)
-
Merger Control and FDI Outlook for 2023 (January 30, 2023)
- FTC Announces New HSR Filing Fees Of Up to $2.25 Million and Revised HSR Thresholds for 2023 (January 25, 2023)
- Medicare Rules: Promoting Competition? (November 15, 2022)
- FTC Announces 2022 Revised Jurisdictional and Filing Fee Thresholds (January 24, 2022)
- Federal Agencies Issue New Draft Policy Statement Regarding Standard Essential Patent Licensing and Remedies, DOJ Seeks Public Comments
(December 7, 2021)
- FTC, DOJ Announce Suspension of HSR Early Termination
(February 5, 2021)
- FTC Announces Revised Thresholds for Interlocking Directorates
(February 2, 2021)
Cookie Settings
